Patrick A. F. Dixon

478 total citations
29 papers, 368 citations indexed

About

Patrick A. F. Dixon is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Patrick A. F. Dixon has authored 29 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Biochemistry. Recurrent topics in Patrick A. F. Dixon's work include Eicosanoids and Hypertension Pharmacology (6 papers), Metabolism and Genetic Disorders (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Patrick A. F. Dixon is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (6 papers), Metabolism and Genetic Disorders (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Patrick A. F. Dixon collaborates with scholars based in Nigeria, United Kingdom and Australia. Patrick A. F. Dixon's co-authors include Robert L. Smith, John Caldwell, Robert G. Fassett, Caroline Pardy, R. Ting, Timothy M. E. Davis, P. L. Drury, Christian Ehnholm, Peter G. Colman and M.J. Whiting and has published in prestigious journals such as Analytical Chemistry, Diabetologia and Biochemical Pharmacology.

In The Last Decade

Patrick A. F. Dixon

26 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick A. F. Dixon Nigeria	11	96	88	82	67	49	29	368
William Cacini United States	12	144 1.5×	29 0.3×	51 0.6×	43 0.6×	23 0.5×	28	463
G M Dappen France	7	160 1.7×	71 0.8×	26 0.3×	21 0.3×	32 0.7×	10	528
Moti Rosenstock Israel	13	256 2.7×	73 0.8×	23 0.3×	48 0.7×	38 0.8×	19	574
S Pascal Belgium	8	94 1.0×	68 0.8×	39 0.5×	18 0.3×	26 0.5×	13	410
Masanobu Horie Japan	8	83 0.9×	37 0.4×	52 0.6×	9 0.1×	39 0.8×	28	246
Takashi Igarashi Japan	11	197 2.1×	22 0.3×	65 0.8×	111 1.7×	9 0.2×	26	425
D. B. Tonks Canada	9	80 0.8×	61 0.7×	24 0.3×	17 0.3×	21 0.4×	21	410
F.R. Hindriks Netherlands	8	73 0.8×	72 0.8×	12 0.1×	45 0.7×	21 0.4×	14	347
Christian Tschanz United States	14	44 0.5×	17 0.2×	44 0.5×	86 1.3×	13 0.3×	18	383
G F Grinstead United States	9	134 1.4×	99 1.1×	7 0.1×	42 0.6×	16 0.3×	11	392

Countries citing papers authored by Patrick A. F. Dixon

Since Specialization

Citations

This map shows the geographic impact of Patrick A. F. Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. F. Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. F. Dixon more than expected).

Fields of papers citing papers by Patrick A. F. Dixon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick A. F. Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. F. Dixon. The network helps show where Patrick A. F. Dixon may publish in the future.

Co-authorship network of co-authors of Patrick A. F. Dixon

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick A. F. Dixon. A scholar is included among the top collaborators of Patrick A. F. Dixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick A. F. Dixon. Patrick A. F. Dixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Babalola, Chinedum P., et al.. (2011). Disposition of quinine and its major metabolite, 3-hydroxyquinine in patients with liver diseases. 3(3). 25–29. 2 indexed citations

Drury, P. L., R. Ting, Diana Zannino, et al.. (2010). Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 54(1). 32–43. 152 indexed citations

Babalola, Chinedum P., et al.. (2010). Quinine pharmacokinetics and toxicity in African subjects. 14(1). 1 indexed citations

Babalola, Chinedum P., Oluseye O. Bolaji, Festus A. Ogunbona, & Patrick A. F. Dixon. (1996). Relationship Between Plasma and Saliva Quinine Levels in Humans. Therapeutic Drug Monitoring. 18(1). 30–33. 4 indexed citations

Babalola, Chinedum P., Oluseye O. Bolaji, Patrick A. F. Dixon, & Festus A. Ogunbona. (1993). Column liquid chromatographic analysis of quinine in human plasma, saliva and urine. Journal of Chromatography B Biomedical Sciences and Applications. 616(1). 151–154. 21 indexed citations

Onyeji, Cyprian O., Patrick A. F. Dixon, & Festus A. Ogunbona. (1992). An in-vitro study of chloroquine transport in the rat submaxillary gland. Journal of Pharmacy and Pharmacology. 44(2). 136–138. 2 indexed citations

Onyeji, Cyprian O., et al.. (1992). Disposition of quinine in rats with induced renal failure. Pharmacy World & Science. 14(4). 185–190.

Bolaji, Oluseye O., Chinedum P. Babalola, & Patrick A. F. Dixon. (1991). Characterization of the principal metabolite of quinine in human urine by¹H-n.m.r. spectroscopy. Xenobiotica. 21(4). 447–450. 9 indexed citations

Onyeji, Cyprian O., Festus A. Ogunbona, & Patrick A. F. Dixon. (1989). Excretion of proguanil in human saliva. Journal of Pharmacy and Pharmacology. 41(12). 872–873. 6 indexed citations

10.

Dixon, Patrick A. F., et al.. (1986). The effect of some hepatotoxins on the sulphoxidation of cimetidine in rat. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 83(2). 385–386. 4 indexed citations

11.

Joseph, Christy & Patrick A. F. Dixon. (1984). Possible prostaglandin―mediated effect of diethylcarbamazine on rat uterine contractility. Journal of Pharmacy and Pharmacology. 36(4). 281–282. 1 indexed citations

12.

Joseph, Christy & Patrick A. F. Dixon. (1984). A possible cytochrome P-450-mediated N-oxidation of diethylcarbamazine. Journal of Pharmacy and Pharmacology. 36(10). 711–712. 2 indexed citations

13.

Dixon, Patrick A. F.. (1984). Evolutionary trend in the metabolic oxidation of chlorpromazine. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 77(1). 135–137. 2 indexed citations

14.

Dixon, Patrick A. F., et al.. (1983). Effect of Drug Pretreatment on the Metabolic Oxidation of Chlorpromazine in Rat. Pharmacology. 27(3). 176–179. 3 indexed citations

15.

Dixon, Patrick A. F. & John Caldwell. (1978). The fate of dichlorophen in the rat. European Journal of Drug Metabolism and Pharmacokinetics. 3(2). 95–98. 4 indexed citations

16.

Caldwell, John, et al.. (1978). Studies on the Metabolism of Arylacetic Acids: 5. The Metabolic Fate of 2-Naphthylacetic Acid in the Rat, Rabbit and Ferret. Xenobiotica. 8(9). 525–534. 15 indexed citations

17.

Dixon, Patrick A. F., et al.. (1977). Metabolism of Arylacetic Acids: 1. The Fate of 1-Naphthylacetic Acid and its Variation with Species and Dose. Xenobiotica. 7(11). 695–706. 19 indexed citations

18.

Dixon, Patrick A. F., John Caldwell, & Robert L. Smith. (1977). Metabolism of Arylacetic Acids: 3. The Metabolic fate of Diphenylacetic Acid and its Variation with Species and Dose. Xenobiotica. 7(12). 717–725. 13 indexed citations

19.

Dixon, Patrick A. F., John Caldwell, Christopher Woods, & Robert L. Smith. (1976). Influence of Chemical Structure on the Pattern of Conjugation in vivo and in vitro of Some Arylacetic Acids in the Rat. Biochemical Society Transactions. 4(1). 143–145. 7 indexed citations

20.

Dixon, Patrick A. F., et al.. (1955). Direct Spectrophotometric Determination of Uranium in Aqueous Solutions. Analytical Chemistry. 27(6). 877–880. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact